The NF-κB Pathway and Cancer Stem Cells

Area of Science:

• Molecular Biology
• Oncology
• Immunology

Background:

• Nuclear factor kappa B (NF-κB) is a key regulator of inflammation and immune responses.
• Dysregulated NF-κB signaling is implicated in various cancers, promoting tumor cell survival, proliferation, and metastasis.
• The cancer stem cell model highlights a subset of cells responsible for tumor initiation, treatment resistance, and metastasis.

Purpose of the Study:

• To review the existing evidence linking NF-κB signaling to cancer stem cell biology.
• To understand how NF-κB influences the properties of cancer stem cells.

Main Methods:

• Literature review of studies investigating NF-κB pathways in cancer.
• Analysis of research connecting NF-κB targets to cancer stem cell characteristics.

Main Results:

• NF-κB signaling downstream of oncogenic pathways (e.g., RAS, BCR-ABL, Her2) regulates genes critical for cancer stem cell functions.
• Evidence suggests NF-κB contributes to cancer stem cell survival, self-renewal, and resistance to therapy.
• NF-κB activity is associated with the invasive and metastatic potential of cancer stem cells.

Conclusions:

• NF-κB signaling plays a significant role in the biology of cancer stem cells.
• Targeting NF-κB may offer a therapeutic strategy to eliminate cancer stem cells and prevent tumor recurrence and metastasis.